Mudanças entre as edições de "Ooth muscles. Rev Pharm Harmful 1977, 17:149?66. fifty three. Chad JE, Eckert R: Calcium domains"

De Mundo Sirrus
Ir para: navegação, pesquisa
(Ooth muscles. Rev Pharm Harmful 1977, 17:149?66. fifty three. Chad JE, Eckert R: Calcium domains)
 
(Sem diferença)

Edição atual tal como às 21h32min de 12 de outubro de 2019

J NeuroGSK-J4 site Immunol 2008, 201:121?27. Tel G, Ozturk M, Duru ME, Harmandar M, Topcu G: Chemical composition of your critical oil and hexane extract of Salvia chionantha as well as their antioxidant and anticholinesterase functions. Meals Chem Toxicol 2010, forty eight:3189?193. 61. Needleman P, Truk J, Jakschik BA, Morrison AR, Lefkowith JB: Arachidonic acid metabolism. Annu Rev Plant Physiol Plant Mol Biol 1986, 55:sixty nine?02. 62. Schaible AM, Koeberle A, Northoff H, Lawrenz B, Weinigel C, Barz D, Werz O, Pergola C: High potential for leukotriene biosynthesis in peripheral blood during pregnancy. Kanda H, Kobayashi K, Yamanaka H, Noguchi K: COX-1-dependent prostaglandin D2 in AP1903 site microglia contributes to neuropathic ache through DP2 receptor in spinal neurons. 53. Chad JE, Eckert R: Calcium domains linked with individual channels can account for anomalous voltage relations of CA-dependent responses. Biophysical J 1984, 45:993?ninety nine. fifty four. Brenner T, Nizri E, Amitay YH, Wirguin I: Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation. J Neuroimmunol 2008, 201:121?27. fifty five. Carrasco MJ, Escarcega RO, Alexandro SF, Riebeling C, Cervera R: Therapeutic possibilities in autoimmune Myasthenia gravis. Autoimmunity Rev 2007, six:373?seventy eight. fifty six. Turner C: A review of Myasthenia gravis: Pathogenesis, scientific attributes and treatment method. Curr Anaes Crit Care 2007, eighteen:15?three. fifty seven. McGleenon BM, Dynan KB, Passmore AP: Acetylcholinesterase inhibitors in Alzheimer's disorder. Br J Clin Pharmacol 1999, forty eight:471?eighty. 58. Perry NSL, Houghton PJ, Jenner P, Keith A, Perry EK: Salvia lavandulaefolia crucial oil inhibits cholinesterase in vivo. Phytomedicine 2002, nine:forty eight?one. 59. Savelev S, Okello E, Perry NSL, Wilkins RM, Perry EK: Synergistic and antagonistic interactions of anticholinesteraseterpenoids in Salvia lavandulaefolia crucial oil. Pharm Biochem Behav 2003, 75:661?sixty eight. sixty. Tel G, Ozturk M, Duru ME, Harmandar M, Topcu G: Chemical composition on the necessary oil and hexane extract of Salvia chionantha and their antioxidant and anticholinesterase actions. Food Chem Toxicol 2010, forty eight:3189?193. sixty one. Needleman P, Truk J, Jakschik BA, Morrison AR, Lefkowith JB: Arachidonic acid metabolic rate. Annu Rev Plant Physiol Plant Mol Biol 1986, fifty five:sixty nine?02. 62. Schaible AM, Koeberle A, Northoff H, Lawrenz B, Weinigel C, Barz D, Werz O, Pergola C: Large ability for leukotriene biosynthesis in peripheral blood while pregnant. Prostaglandins Leuko Essent Fatty Acid 2013, 13:S0952 3278. 63. Scott PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/26392056 JP, Peters-Golden M: Modern-day pharmacotheraphy of lung ailment: anti-leukotriene brokers to the procedure of lung condition. Amer J Resp Crit PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25027405 Care Med 2013, 188:538?44. sixty four. Loux JJ, Delpama PD, Yankell SL: Antipyretic screening of aspirin in rats. Toxicol Appl Pharm 1972, 22:672?seventy five. sixty five. Geusens P, Emans PJ, Jong JJ, Bergh J: NSAIDs and fracture healing. Curr Opin Rheumatol 2013, twenty five:524?31.Janbaz et al. BMC Complementary and Alternate Medication 2014, fourteen:71 http://www.biomedcentral.com/1472-6882/14/Page 12 of66. Kanda H, Kobayashi K, Yamanaka H, Noguchi K: COX-1-dependent prostaglandin D2 in microglia contributes to neuropathic agony via DP2 receptor in spinal neurons. Glia 2013, 61:943?fifty six.